Elusys Therapeutics
| Company type | Private company |
|---|---|
| Founded | 1998 |
| Headquarters | Pine Brook, New Jersey |
Key people | Dr. Elizabeth G. Posillico (Chief Executive Officer, President and Director) |
| Website | elusys.com |
Elusys Therapeutics is a biopharmaceutical company founded in Pine Brook, New Jersey in 1998. The company specializes in the development of antibodies for the treatment infectious diseases. The antibodies are developed from protein complexes called heteropolymers which can bind to specific pathogens on one side and red blood cells on the other side.
The pathogens will be dragged to the liver where they will be destroyed. The antibodies have a potential to be used for the treatments of many blood-borne diseases. Currently, the company focuses on the late-stage clinical trials of Anthim (Obiltoxaximab) to be used for treatment and prevention of inhaled anthrax.